Site-specific pathology in breast reduction mammoplasty.

Objective: To investigate the feasibility and clinical value of site-specific pathology in breast reduction mammoplasty.

Methods: Totally 127 patients who underwent breast reduction mammoplasty from June 2007 to June 2010 were included. Pathologic specimens were sent for frozen pathology according to the clock-wise method. Patients with confirmed cancer were arranged for conservative breast surgery.

Results: Of the 127 patients, 53 patients (41.7%) had gland hyperplasia; 7 had fibroadenoma (5.5%); 1 (0.79%) had ductal carcinoma in situ, who underwent breast conserving surgery, following by chemotherapy and radiotherapy, no relapse was noted during the three-year follow-up.

Conclusion: Clock-wise method is useful to locate the tumor and ensure the patients to receive skin-spared breast resection even cancer is detected.